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relevanceAbstract Four new mixed-ligand complexes of manganese(II) of the composition [Mn(pa)-
(L)(H2O)], where paH = picolinic acid and LH= acetoacetanilide (aaH), o-acetoacetanisidide
(o-aansH), o-acetoacetotoluidide (o-aatdH) or ethylacetoacetate (eacacH), have been synthesized
by the interaction of MnCl2Æ4H2O with the said ligands in aqueous-ethanol medium. The complexes
so obtained have been characterized on the basis of elemental analyses, molar conductance and
magnetic measurements, thermogravimetric analyses, mass, EPR, infrared and electronic spectral
studies. Synthesized complexes have shown signiﬁcantly greater antibacterial activity against
Escherichia coli and Vibrio cholera than ligands. The 3D-molecular modeling and analysis for bond
lengths and bond angles have also been carried out for one of the representative compound
[Mn(pa)(aa)(H2O)] (1) to substantiate the proposed structures.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
The half-ﬁlled 3d5 shell of the Mn(II) ion makes it behave as a
spherically polarizable ion, with no crystal-ﬁeld stabilization
energy in the high-spin complexes (Blake and Cotton, 1964).
Therefore, there are no electronic restraints, and the structures
of Mn(II) complexes are those that minimize the sterical repul-
sion: octahedral and tetrahedral; although in biological sys-
tems there are also examples of ﬁve-coordination (Stallings
Manganese(II) chelates of bioinorganic and medicinal relevance: Synthesis, characterization, antibacterial activity S55et al., 1985) or even seven-coordination (Gill and Eisenberg,
2001; Johnson et al., 2001).
The great upsurge in the coordination chemistry of manga-
nese(II) involving oxygen and nitrogen donor ligands comes
from the increasing recognition of the biological role of this
metal ion (Christou, 1989; Pecoraro et al., 1994; Riley, 1999;
Que and True, 1990; Pecoraro, 1992). Among the ﬁrst-row
transition metal ions, the high-spin Mn(II) centers are quite
desirable because they contain the highest possible number
of unpaired electrons (Yokum and Pecoraro, 1999). Mn(II)
is found in a variety of enzymes such as pyruvate carboxylase,
oxaloacetate decarboxylase, superoxide dismutases and dia-
mine oxidases, among others (Mukhopadhyay et al., 2004).
Manganese is also well known to be required for oxygen evo-
lution in the photosystem-II (Hurley et al., 1960; Tuormaa,
1996; Hughes, 1988). Moreover, it is involved in many biolog-
ical processes including hydrogen peroxide decomposition or
superoxide dismutation, and it appears to play an important
role in several metabolic processes such as bone growth, glu-
cose tolerance, reproduction and development of the inner
ear (Vaiana et al., 2007).
Mitochondria play a central role in cell life and death
and are known to be important in a wide range of diseases
including the cancer, diabetes, cardiovascular disease, etc.
(Armstrong, 2007). The unique structure and functional char-
acteristics of mitochondria enable the selective targeting of
drugs designed to modulate the function of this organelle for
therapeutic gain (Gogvadze et al., 2009). Manganese(II) ions
are the required co-factor for many ubiquitous enzymes. The
mitochondria can accumulate Mn(II) ions through an ATP
dependent Ca transporter (Frezza and Gottlieb, 2009). Trans-
port mechanism of Mn(II) in vivo may make Mn(II)-based
compounds possible to be tumor-targeted. Research has pro-
ven that Mn(II) ions were mainly up taken and transported
by a divalent metal transporter and transferring receptor
(Aschner et al., 2007), which were highly expressed in some tu-
mor tissues (Calzolari et al., 2007; Sciot et al., 1990).
Two new Mn(II) complexes in the ONNN-donor coordina-
tion matrix, namely [(Etdpa)MnCl2] (1) and [(Adpa)Mn(Cl)
(H2O)] (2) are reported (Chen et al., 2010) to be active against
the four cancer cells (MCF-7, ECA-109, U251, HeLa). Espe-
cially, complex (2) inhibits the proliferation of cancer cells
MCF-7 and U251 with IC50 values of 6.5 and 9.5 lM. The
highly inhibiting activity complex (2) on the tumor cells
in vitro may be due to the good mitochondrial membrane
potentials induced permeation. The direct interaction between
the complex (2) with mitochondria could be the main reason
for its cytotoxic activity.
b-Diketones and related derivatives are considered to be a
class of very important ligands in the growth of coordination
chemistry. Their complexes have been thoroughly studied.
Due to the presence of two oxygen donor atoms and facile
keto-enol tautomerism, they easily coordinate with metal ions
after deprotonation of the enolic hydrogen and give rise stable
metal complexes with six membered chelate rings. Water
molecules are usually associated with metal b-diketones when
the coordination number of the metal ion is more than four
(Maurya et al., 1991; Maurya, 2003).
Found in humans as a metabolite of the amino acid trypto-
phan and is, therefore, less toxic to mammals (Yasumatsu et
al., 2007), picolinic acid (pyridine-2-carboxylic acid) forms a
variety of metal complexes. Picolinic acid and its metalcomplexes have been the target of several studies in the last
few years because of their broad spectrum of physiological ef-
fects (Yasui et al., 2002; Sakurai et al., 1995; Hepburn and Vin-
cent, 2003; Chaudhary et al., 2005; Kanth and Mishra, 2005).
In the search for developing compounds that can replace or
mimic insulin, the bis(picolinato)oxovanadaium(IV) complex,
[VO(pic)2] (having N2O2 coordination environment) has been
found to be a good candidate to do so and to provide a
long-term acting insulin-mimetic activity [Yasui et al., 2002;
Sakurai et al., 1995]. The insulinomimetic effect of this com-
pound results from its ability to normalize the blood glucose
levels in several types of diabetic animals. Tris(picolinato)chro-
mium(III), Cr(pic)3 is considered to be among the most popu-
lar nutritional supplements (Hepburn and Vincent, 2003) and
the compound showed DNA cleavage in the presence and ab-
sence of H2O2 (Chaudhary et al., 2005). Also, iron, zinc and
copper complexes of picolinic acid exhibited antibacterial
and antifungal activities (Kanth and Mishra, 2005). Moreover,
Fe(III) and Mn(II) picolinates were used to disproportionate
the superoxide ion (O2 ), an ion which may cause damage to
the animal cells, in a matter related to the metalloprotein
superoxide dismutase (SOD) (Jain and Bhattacharyya, 2005;
Yamaguchi et al., 1986). The picolinic acid is known to bind
a variety of metal ions ranging from alkali metals, transition
metals and lanthanides (Goher and Mautner, 1995; Mautner
et al., 1997; Zhang et al., 2005; Heren et al., 2006a,b; Vargova
et al., 2004; Chattopadhyay et al., 2003; Orjiekwe et al., 2005;
Wu et al., 2005; Sendor et al., 2003; Fang et al., 1996). This
may result from the versatility of the picolinate ion to act as
a monodentate ligand via the oxygen atoms of the carboxylate
group or through its pyridine nitrogen atom or to act as a
bidentate chelating agent via both the nitrogen and oxygen
(Mautner and Massoud, 2007).
Maurya et al. have recently reported some new monomeric
(Maurya et al., 2003a,b,c) and dimeric (Maurya et al., 2008a,b)
manganese(II) complexes with a variety of Schiff bases derived
from o-vanillin and furyl methyl ketone, in tetrahedral and
octahedral stereochemistries. In a recent communication,
Maurya and Sutradhar (2008) have reported the synthesis
and characterization of two mixed-ligand cyanonitrosyl
Mn(I) and two mixed-ligand dinitrosyl Mn(0) complexes
involving {MnNO}6 and {Mn(NO)2}
7 electron conﬁgurations,
respectively.
In view of the diverse and important applications of metal
complexes having (N,O)- and (O,O)-donor coordination
environments in general and manganese compounds in the
(N,O)-donor coordination matrix in particular, a study was
undertaken of the coordination chemistry of some mixed-
ligand manganese(II) complexes involving picolinic acid (O,N-
donor) and some b-diketoenolates (O,O-donor), such as,
actoacetanilide (aaH), o-acetoacetanisidide (o-aansH), o-aceto-
acetotoluidide (o-aatdH) or ethylacetoacetate (eacacH).2. Experimental
2.1. Materials
Manganese(II) chloride tetrahydrate (BDH, Chemicals,
Bombay), 2-picolinic acid (Sisco Chem. Pvt. Ltd., Mumbai),
acetoacetanilide, o-acetoacetanisidide, o-acetoacetotoluidide
(Aldrich Chemical Co., USA), ethylacetoacetate and DMF
Table 1 Analytical data and some physical properties of the synthesized complexes.
S. No. Complexes
(Empirical formula) (M.W.)
Found (Calcd), (%) Color Decomp. temp. (C) KM (X1 cm2 mol1) Yield (%) leﬀ (B.M.)
C H N Mn
1 [Mn(pa)(aa)(H2O)] 51.98 4.24 7.49 14.58 Leaf brown 244 12.4 60 5.86
(C16H16N2O5Mn) (370.93) (51.76) (4.31) (7.55) (14.81)
2 [Mn(pa)(o-aans)(H2O)] 50.68 4.62 6.65 13.49 Leaf brown 258 14.3 70 5.89
(C17H18N2O6Mn) (400.93) (50.88) (4.49) (6.98) (13.70)
3 [Mn(pa)(o-aatd)(H2O)] 52.89 4.80 7.45 14.10 Brown 265 13.6 64 5.92
(C17H18N2O5Mn) (384.93) (53.00) (4.68) (7.27) (14.27)
4 [Mn(pa)(eacac)(H2O)] 44.60 4.45 4.51 16.73 Leaf brown 240 13.0 68 5.85
(C12H15NO6Mn) (323.93) (44.45) (4.63) (4.32) (16.96)
S56 R.C. Maurya et al.(Tomas Baker Chemical Ltd., Mumbai), ethanol (Bengal
Chemicals and Pharmaceuticals Ltd., Kolkata) were used as
purchased. All other chemicals used were of analytical reagent
(AR) grade.
2.2. Preparation of mixed-ligands complexes
To a solution of 0.001 M of picolinic acid (0.123 g) in 10 mL of
ethanol was added 0.001 M of acetoacetanilide (0.177 g),
o-actoacetanisidide (0.207 g), o-actoacetotoluidide (0.191 g)
or ethyl acetoacetate (0.13 mL) in 10 mL of ethanol. The
resulting mixture of the two appropriate ligands was added
slowly with constant stirring to the solution of 0.001 M of
MnCl2Æ4H2O (0.198 g) in 1 mL water and 10 mL of ethanol.
After reﬂuxing the mixture for 4 h, the pH of the solution
was raised by drop wise addition of dilute aq. NH3 solution
when a dark brown solid precipitated immediately. After heat-
ing the mixture over a hot plate at 50 C for 15 min, the solid
mass was suction ﬁltered, repeatedly washed with 1:1 ethanol
water mixture and dried in vacuo. The analytical data of the
complexes are given in Table 1.
3. Physical methods
Carbon, hydrogen and nitrogen were determined micro-ana-
lytically at C.D.R.I., Lucknow. Manganese was determined
as ammonium manganese phosphate monohydrate, MnNH4
PO4ÆH2O using the standard procedure (Vogel, 1979) after
decomposing the complexes with concentrated nitric acid and
then with concentrate sulphuric acid. From the weight of
MnNH4PO4ÆH2O manganese content of the complex was cal-
culated in each case.
Solid-state infrared spectra were recorded in KBr pellets
using a Perkin–Elmer model 1620 FT-IR spectrophotometer
and mass spectra of a compound was recorded at S.A.I.F.,
C.D.R.I., Lucknow. Magnetic measurements were performed
by the vibrating sample magnetometer method at Indian Insti-
tute of Technology, Roorkee. Conductance Measurements
were made at room temperature in dimethylformamide
(DMF) solution using Toshniwal Conductivity Bridge and
dip type cell with a smooth platinum electrode of a cell con-
stant 1.02. The decomposition temperatures of the complexes
were recorded using an electrically operated melting point
apparatus (Kumar Industries, Bombay) of heating capacity
up to 360 C. The X-Band EPR spectra of compounds were re-
corded at LNT on ESP X-Band EPR spectrophotometer using
a powdered sample at the microwave frequency of 9.1 GHz.Thermogravimetric analysis was done by heating the sample
at the rate of 15 C min1 up to 1000 C on a thermal analyzer
at R.S.I.C., I.I.T., Mumbai. Electronic spectra of the com-
plexes were recorded in DMF on a Systronics Double Beam
UV–vis Spectrophotometer, model 2201.
3.1. 3D-Molecular modeling studies
The 3D-molecular modeling of a representative compound was
carried out on a CS Chem 3D Ultra Molecular Modeling and
Analysis Programme (www.cambridgesoft.com). It is an inter-
active graphics programme that allows rapid structure build-
ing, geometry optimization with minimum energy and
molecular display. It has the ability to handle transition metal
compounds.
4. Results and discussion
The mixed-ligand manganese(II) complexes in the present
investigation were prepared as given in Scheme 1. These com-
plexes are found to be air stable. They are thermally stable and
their decomposition temperatures are given in the Table 1.
These are insoluble in the most of the common organic sol-
vents but are fairly soluble in DMF. These complexes are char-
acterized on the basis of their elemental analysis, molar
conductance and magnetic measurements, thermogravimetric
analysis, infrared spectra, electron spin resonance, mass and
electronic spectral studies.
4.1. Infrared spectral studies
The characteristic IR spectral bands and their plausible assign-
ments of the synthesized complexes are given in Table 2. In the
complexes (1)–(3), the two important modes on account
of coordination of acetoacetanilide, o-acetoacetanisidide or
o-acetoacetotoluidide (acetoacetylarylamides) anions are
m(C‚O) (acetyl carbonyl) and m(C‚O) (amide carbonyl).
These two modes have been observed at 1571–1578 and
1602–1604 cm1, respectively, in the said complexes, which
are in agreement with the reported results (Maurya and Singh,
2004). These three complexes exhibit m(NH) mode at 3280 cm
1, which is almost similar to the uncoordinated acetoacetyla-
rylamides. This suggests that the amide nitrogen of the aceto-
acetylarylamides is not taking part in the coordination. The
characteristic absorption bands due to coordinated ethyl ace-
toacetate anion are m(C‚O) (acetyl) and m(C‚C) modes,
and these have been observed at 1604 and 1571 cm1,
Scheme 1 Synthesis of mixed-ligand Mn(II)complexes.
Table 2 Some important IR spectral bands (cm1) of the synthesized complexes.
S. No. Complexes mas(COO)
(pa) (a)
ms(COO)
(pa) (b)
D= (a)  (b) m(C‚O)
(acetyl
carbon.)
m(C‚O)
(Amide
carbon.)
m(C‚C) m(C‚N) (pa) PRB mode m(OH) m(Mn–O) m(Mn–N)
1 [Mn(pa)(aa)(H2O)] 1643 1348 295 1578 1602 –
a 1030 3418 545 457
2 [Mn(pa)(o-aans)(H2O)] 1643 1347 296 1571 1604 –
a 1032 3448 546 459
3 [Mn(pa)(o-aatd)(H2O)] 1640 1348 293 1571 1604 –
a 1032 3448 546 459
4 [Mn(pa)(eacac)(H2O)] 1644 1347 297 1604 – 1571
b 1032 3448 546 459
PRB= pyridine ring breathing mode.
a Merged with m(C‚O) amide.
b Merged with m(C‚O) acetyl.
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the data reported elsewhere (Maurya and Rajput, 2004) for
such compounds.
Picolinic acid used as a co-ligand in all the complexes con-
tains two potential donor sites: (i) the pyridine ring nitrogen
and (ii) the carbonyl oxygen. Coordination of the pyridine ring
nitrogen of the picolinic acid should display a strong band due
to m(C‚N) at 1600 cm1 in these complexes. But due to
presence of m(C‚O) (amide/acetyl carbonyl) of the ligands
acetoacetanilide/o-acetoacetanisidide/o-acetoacetotoluidide
and ethyl acetoacetate in this range, it is difﬁcult to say with
certainty the coordination of ring nitrogen of picolinic acid
to manganese. However, the presences of the pyridine ring
breathing mode (Maurya et al., 1995) at 1030 cm1 in these
complexes suggests the coordination of the pyridine ring nitro-
gen to manganese in these complexes. The asymmetric and
symmetric vibrations of the carboxylate group of picolinic acid
appear at 1643–1644 and 1347–1348 cm1 (Jain et al., 2004),
respectively, showing a difference (Maurya et al., 2003a,b,c)
of 293–297 cm1. These observations suggest the monodentate
coordination of the carboxylate group. The non-ligand bands
occurring at 545–546 cm1 (broad) and 457–459 cm1 (sharp)have been assigned to m(Mn–O) and m(Mn–N), respectively
(Maurya et al., 2003a,b,c).
In all the complexes the presence of coordinated/lattice
water is indicated by the presence of a broad band in the region
of 3418–3448 cm1. The IR spectrum of compound [Mn(pa)
(o-aatd)(H2O)] (3) is given in Fig. 1.
4.2. Conductance measurements
The molar conductance values of the synthesized complexes
in 103 M DMF solution are in the range 12.6–16.3
ohm1 cm2 mol1 (Table 1). These results are indicative of
the non-electrolytic nature of these complexes (Howader
et al., 2008; Geary, 1971).
4.3. Magnetic measurements
The manganese(II) belongs to S = 5/2 system. Magnetically
dilute manganese(II) complexes usually exhibit magnetic mo-
ments close to their spin only value of 5.92 B.M. because of
the additional stability of the half ﬁlled d-shell. At room tem-
perature, the observed values of the magnetic moment for the
Figure 1 IR spectrum of [Mn(pa)(o-aatd)(H2O)] (3).
Table 3 Electronic spectral data of the synthesized complexes.
Compound no. Complexes kmax (nm) m (cm
1) e (L mol1 cm1) Peak assignment
(2) [Mn(pa)(o-aans)(H2O)] 286 34,965 2287 Intra ligand transitions
355 28,169 2262
391 25,575 2285 Ligandﬁ metal charge transfer transition
(4) [Mn(pa)(eacac)(H2O)] 272 36,764 2290 Intra ligand transitions
358 27,932 2278
385 25,974 2284 Ligandﬁ metal charge transfer transition
S58 R.C. Maurya et al.present complexes are in the range of 5.85–5.92 B.M. (Table 1),
as expected for a simple of S = 5/2 paramagnet with a 6S
ground state. These data suggest that the complexes under this
investigation are mononuclear. The magnetic moment of both
octahedral and tetrahedral complexes should be the same since
a 6S ground state persists in both symmetries. Thus, the mag-
netic results give no speciﬁc information about the geometry of
these compounds (Lal et al., 2007).
4.4. Electronic spectral studies
Electronic spectra of two complexes (1) and (4) were recorded
in 103 M DMF solutions. The electronic spectral peaks
observed in each of the complexes along with the molar extinc-
tion coefﬁcients are given in the Table 3. The two high inten-
sity peaks in the ultraviolet region in each of the complexes
are due to intra ligand n–p*/p–p* transitions, while the third
peak near the visible region may be due to the ligand to metal
charge transfer transitions (Bonomon et al., 1991).
4.5. EPR spectral studies
The X-band EPR spectrum of a representative compound
namely [Mn(pa)(eacac)(H2O)] (4) (Fig. 2) at liquid nitrogentemperature (LNT) was recorded in the powder form at the
microwave frequency 9.1 GHz without using DPPH as a mar-
ker. The EPR spectrum of a manganese(II) complex should ex-
hibit six hyperﬁne lines (Mn, I= 5/2). However, this complex
shows an isotropic spectrum with g= 2.01 at LNT. No other
signal is observed in the 4000 G scan spectrum as could have
been expected for a non cubic manganese(II) complex with an
appreciable zero ﬁeld splitting. Such a simple one line spectrum
devoid of hyperﬁne structure has been interpreted as arising
from a manganese(II) complex with a neighboring atom mag-
netic interaction (Yasumatsu et al., 2007; Thimmaiah et al.,
1985).
4.6. Mass spectral studies
The FAB mass spectrum of a representative complex
[Mn(pa)(eacac)(H2O)] (4) (Fig. 3) was recorded on a JEOL
SX 102/DA-6000 mass spectrometer/data system using
xenon/argon (6 kV, 10 mA) as the FAB gas in the m/z range
of 89.98–355.54. The mass spectral peaks observed at 136,
137 and 154 m/z are matrix (m-nitrobenzyl alcohol) peaks.
The appearance of a peak at 307 m/z is consistent with the
molecular mass of the present compound excluding one water
molecule present therein, which is supposed to be lost before
Figure 2 EPR spectrum of [Mn(pa)(eacac)(H2O)] (4).
Figure 3 Mass spectrum of [Mn(pa)(eacac)(H2O)] (4).
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289 m/z in the complex might be correlated possibly with the
following types of ion associations:
½MnðpaÞðeacacÞþ ¼ 307
½MnðpaÞðeacacÞþð307Þ  ½CH3þð15Þ  3½Hþ ¼ 289
½paþð123Þ þ ½matrixþð137Þ ¼ 260
½MnðpaÞþð176Þ þ 2½Hþ ¼ 178
These results are consistent with the proposed molecular com-
position of the complex (4).
4.7. Thermogravimetric studies
The thermogravimetric analysis of two representative com-
pounds, namely, [Mn(pa)(o-aans)(H2O)] (2) and [Mn(pa)(eaca-
c)(H2O)] (4) were carried out in the temperature range of20–1000 C at the heating rate of 15 C/min. The compound
(2) shows a weight loss of 4.63% at 160 C, which corresponds
to the elimination of one molecule of coordinated (Maurya
et al., 2003a,b,c) water per molecule of the complex (calculated
weight loss = 4.48%). The second weight loss in this com-
pound was noticed at 370 C, which corresponds to the decom-
position of o-aans ligand group from the complex (observed
weight loss: 52%, calculated weight loss: 55.38%). The third
weight loss was noticed at 720 C which roughly corresponds
to the removal of all the ligand moieties from the complex
(observed weight loss: 78%, calculated weight loss: 86.22%)
The ﬁnal residue (observed, 22%) corresponds to MnO2
(calculated, 21.66%).
The thermogram of compound (4) shows the ﬁrst weight
loss of 5.12% at 126 C against a calculated weight loss of
5.54%. This corresponds to the removal of one coordinated
(Maurya et al., 2003a,b,c) water molecule from the complex.
Figure 4 TG curve of [Mn(pa)(eacac)(H2O)] (4).
Table 4 Antibacterial study of the picolinic acid and metal
Complexes.
S. No. Compound Compound
zone of inhibition in (nm)
E. coli V. cholera
1 Piconilic acid 28 27
2 [Mn(pa)(o-aans)(H2O)] (2) 32 33
3 [Mn(pa)(eacac)(H2O)] (4) 31 35
S60 R.C. Maurya et al.The second weight of 48% was noticed at 410 C against a the-
oretical weight loss of 45.29%, for the removal of an eacacFigure 5 3D Structure ofligand group from the complex. This compound shows a third
weight loss of 78% around 880 C, which corresponds to
removal of all the ligand moieties from the complex (calculated
weight loss: 82.88%). The ﬁnal residue (observed: 22%)
roughly corresponds to MnO2 (calculated: 26.78). The TG
curve of compound (4) is given in Fig. 4.
4.8. Antibacterial screening
One of the co-ligands picolinic acid and the two representative
metal complexes, namely, [Mn(pa)(o-aans)(H2O)] (2) and
[Mn(pa)(eacac)(H2O)] (4) have been screened for their antibac-
terial activity against Escherichia coli and Vibrio cholera at a
concentration of 300 lg cm3 in DMSO by the agar diffusion[Mn(pa)(aa)(H2O)] (1).
Table 5 Various Bond Lengths of Compound [Mn(pa)(aa)(H2O)] (1).
No Atoms Actual bond lengths Optimal bond lengths S. No. Atoms Actual bond lengths Optimal bond lengths
1 C(24)–H(40) 1.1 1.1 23 C(12)–C(13) 1.337 1.337
2 C(23)–H(39) 1.1 1.1 24 C(9)–O(11) 1.7648 1.338
3 C(23)–C(24) 1.337 1.42 25 C(9)–O(10) 1.208 1.208
4 C(22)–H(38) 1.1 1.1 26 C(8)–H(30) 1.1 1.1
5 C(22)–C(23) 1.337 1.42 27 C(7)–H(29) 1.1 1.1
6 C(21)–H(37) 1.1 1.1 28 C(7)–C(8) 1.337 1.503
7 C(21)–C(22) 1.337 1.42 29 C(6)–H(28) 1.1 1.1
8 C(20)–H(36) 1.1 1.1 30 C(6)–C(7) 1.3894 1.337
9 C(20)–C(21) 1.337 1.42 31 C(5)–H(27) 1.1 1.1
10 C(19)–C(24) 1.337 1.42 32 C(5)–C(6) 1.337 1.503
11 C(19)–C(20) 1.337 1.42 33 N(4)–C(5) 1.266 1.266
12 N(18)–H(35) 1.05 1.05 34 C(3)–C(9) 1.351 1.517
13 N(18)–C(19) 1.266 1.462 35 C(3)–C(8) 1.337 1.337
14 C(16)–H(34) 1.113 1.113 36 C(3)–N(4) 1.266 1.462
15 C(16)–H(33) 1.113 1.113 37 O(2)–H(26) 0.986 –
16 C(16)–H(32) 1.113 1.113 38 O(2)–H(25) 0.986 –
17 C(14)–C(16) 1.497 1.497 39 Mn(1)–O(17) 1.81 –
18 C(14)–O(15) 1.7944 1.355 40 O(15)–Mn(1) 1.81 –
19 C(13)–H(31) 1.1 1.1 41 N(4)–Mn(1) 1.846 –
20 C(13)–C(14) 1.337 1.503 42 Mn(1)–O(11) 1.81 –
21 C(12)–N(18) 1.266 1.462 43 Mn(1)–O(2) 1.81 –
22 C(12)–O(17) 1.355 1.355
Table 6 Various Bond Angles of Compound [Mn(pa)(aa)(H2O)] (1).
S. no Atoms Actual bond angles Optimal bond angles S. no. Atoms Actual bond angles Optimal bond angles
1 H(39)–C(23)–C(24) 120.0002 120 38 C(9)–O(11)–Mn(1) 86.767 –
2 H(39)–C(23)–C(22) 119.9999 120 39 H(26)–O(2)–H(25) 120.0004 –
3 C(24)–C(23)–C(22) 119.9999 – 40 H(26)–O(2)–Mn(1) 119.9996 –
4 H(38)–C(22)–C(23) 120.0001 120 41 H(25)–O(2)–Mn(1) 120 –
5 H(38)–C(22)–C(21) 119.9999 120 42 C(14)–O(15)–Mn(1) 76.7537 –
6 C(23)–C(22)–C(21) 120.0001 – 43 O(11)–C(9)–O(10) 116.3884 122
7 H(37)–C(21)–C(22) 120 120 44 O(11)–C(9)–C(3) 127.2226 124.3
8 H(37)–C(21)–C(20) 120 120 45 O(10)–C(9)–C(3) 116.389 123
9 C(22)–C(21)–C(20) 120 – 46 H(30)–C(8)–C(7) 119.9998 120
10 H(40)–C(24)–C(23) 119.9999 120 47 H(30)–C(8)–C(3) 120.0001 120
11 H(40)–C(24)–C(19) 120 120 48 C(7)–C(8)–C(3) 120.0001 –
12 C(23)–C(24)–C(19) 120 – 49 H(29)–C(7)–C(8) 121.3316 120
13 H(36)–C(20)–C(21) 120.0002 120 50 H(29)–C(7)–C(6) 121.3319 120
14 H(36)–C(20)–C(19) 119.9997 120 51 C(8)–C(7)–C(6) 117.3366 –
15 C(21)–C(20)–C(19) 120.0001 – 52 H(28)–C(6)–C(7) 120.673 120
16 C(24)–C(19)–C(20) 120 120 53 H(28)–C(6)–C(5) 120.6734 120
17 C(24)–C(19)–N(18) 119.9999 120 54 C(7)–C(6)–C(5) 118.6536 –
18 C(20)–C(19)–N(18) 120.0001 120 55 O(17)–Mn(1)–O(15) 136.7386 –
19 H(34)–C(16)–H(33) 109.5199 109 56 O(17)–Mn(1)–O(11) 89.9999 –
20 H(34)–C(16)–H(32) 109.4613 109 57 O(17)–Mn(1)–N(4) 89.9998 –
21 H(34)–C(16)–C(14) 109.4621 110 58 O(17)–Mn(1)–O(2) 180 –
22 H(33)–C(16)–H(32) 109.4419 109 59 O(15)–Mn(1)–O(11) 109.5001 –
23 H(33)–C(16)–C(14) 109.4419 110 60 O(15)–Mn(1)–N(4) 120.0003 –
24 H(32)–C(16)–C(14) 109.5003 110 61 O(15)–Mn(1)–O(2) 43.2613 –
25 C(16)–C(14)–O(15) 105.6499 120 62 O(11)–Mn(1)–N(4) 104.0001 –
26 C(16)–C(14)–C(13) 105.65 121.4 63 O(11)–Mn(1)–O(2) 90.0002 –
27 O(15)–C(14)–C(13) 148.7001 124.3 64 N(4)–Mn(1)–O(2) 90.0002 –
28 H(35)–N(18)–C(19) 120.0001 118 65 H(27)–C(5)–C(6) 119.9994 120
29 H(35)–N(18)–C(12) 119.9997 118 66 H(27)–C(5)–N(4) 120.0003 113.5
30 C(19)–N(18)–C(12) 120.0002 124 67 C(6)–C(5)–N(4) 120.0002 119
31 H(31)–C(13)–C(14) 119.9997 120 68 C(5)–N(4)–C(3) 124.0001 124
32 H(31)–C(13)–C(12) 120 120 69 C(5)–N(4)–Mn(1) 124.9986 –
33 C(14)–C(13)–C(12) 120.0003 – 70 C(3)–N(4)–Mn(1) 110.9991 –
34 N(18)–C(12)–O(17) 117.8498 – 71 C(9)–C(3)–C(8) 128.9981 117.6
35 N(18)–C(12)–C(13) 117.8503 120 72 C(9)–C(3)–N(4) 110.9995 120
36 O(17)–C(12)–C(13) 124.2999 124.3 73 C(8)–C(3)–N(4) 119.9999 120
37 C(12)–O(17)–Mn(1) 109.5 –
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S62 R.C. Maurya et al.method (Ong and Martelli, 1994; Ollee et al., 1989) using strep-
tomycin as the standard antibacterial agent. The results
obtained are presented in Table 4. It is observed that all the
metal complexes are more potent bactericides than the ligand
picolinic acid. The enhancement in the activity of the com-
plexes may depend upon the metal ions (Thimmaiah et al.,
1985; Franklin and Snow, 1971), viz., size, charge distribution,
shape and redox potential of the metal chelates and chelation.
Moreover, steric and pharmacokinetic factors also play a deci-
sive role in deciding the potency of an antimicrobial agent.
Thus, antibacterial property of the metal complexes is an intri-
cate blend of several contributions (Levingson et al., 1978;
Murukan and Mohanan, 2006).
4.9. 3D-Molecular modeling and analysis
In view of the penta-coordination of the present complexes,
and also taking into account the trigonal bipyramidal
geometry (Cotton et al., 2004) of high-spin penta-coordinate
complexes, the 3D-molecular modeling of compound, [Mn(pa)-
(aa)(H2O)] (1) as a representative, is based on its trigonal bipy-
ramidal structure. The details of bond lengths and bond angles
as per the 3D structure (Fig. 5) are given in Tables 5 and 6,
respectively. For convenience of looking over the different
bond lengths and bond angles, the various atoms of the com-
pound in question are numbered in Arabic numerals. In all,
116 measurements of the bond lengths (43 in numbers), plus
the bond angles (73 in numbers) are listed. Except a few cases,
optimal values of both the bond lengths and the bond angles
are given in the tables along with the actual ones. The actual
bond lengths/bond angles given in Tables 5 and 6 are obtained
as a result of energy optimization in CHEM 3D Ultra, while
the optimal bond length/bond angle values are the standard
bond lengths/bond angles established by the builder unit of
the CHEM 3D. The missing of some values of standard bond
lengths/bond angles may be due to the limitations of the soft-
ware, which we had already noticed in the modeling of other
systems (Maurya and Rajput, 2007; Maurya et al., 2008a,b,Figure 6 Proposed trigonal bipyramidal structure of complexes.2010). In most of the cases, the actual bond lengths and
bond angles are close to the optimal values, and thus the pro-
posed structures of the compound (1) as well as of the
others are acceptable (Maurya and Rajput, 2007; Maurya
et al., 2008a,b, 2010).
5. Conclusions
The satisfactory analytical data and all of the physico-chemical
evidence presented above suggest that the complexes under this
investigation may be formulated as, [Mn(pa)(L)(H2O)] where
paH = 2-picolinic acid, LH = b-diketones: acetoacetanilide
(aaH), o-acetoacetanisidide (o-aansH), o-acetoacetotoluidide
(o-aatdH) or ethylacetoacetate (eacacH). Considering the
monomeric penta-coordination in these complexes, trigonal
bipyramidal structures (Cotton et al., 2004) have been pro-
posed for them as shown in Fig. 6.Acknowledgements
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